Christine Desbiens

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 447 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Clinical Outcomes in Early Breast Cancer With a High 21-Gene Recurrence Score of 26 to 100 Assigned to Adjuvant Chemotherapy Plus Endocrine Therapy

Joseph A. Sparano, Robert J. Gray, Della Makower et al. · JAMA Oncology · 2019 · 168 citations · Full text

Medicine, Endocrinology, Oncology +16

Is Clinical Breast Examination Important for Breast Cancer Detection?

Louise Provencher, Jean‐Charles Hogue, Christine Desbiens et al. · Current Oncology · 2016 · 128 citations · Full text

Medicine, Oncology, Radiology +15

Factors associated with upgrading to malignancy at surgery of atypical ductal hyperplasia diagnosed on core biopsy

Isabelle Deshaies, Louise Provencher, Simon Jacob et al. · The Breast · 2010 · 69 citations · Full text

Medicine, Oncology, Surgery +14